Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in mortality from benign prostatic hyperplasia: a major unheralded health triumph

P Boyle1, P Maisonneuve, A Steg

  • 1Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.

The Journal of Urology
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia.

Urology·1995
Same author

Geographical and temporal patterns of incidence and mortality from prostate cancer.

Urology·1995
Same author

Progress in preventing death from colorectal cancer.

British journal of cancer·1995
Same author

Breast-cancer risk and oral contraceptive use in Slovenian women aged 25 to 54.

International journal of cancer·1995
Same author

Pancreatitis and the risk of pancreatic cancer.

Pancreas·1995
Same author

Epidemiology of malignant melanoma.

British medical bulletin·1995
Same journal

On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

The Journal of urology·2026
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
See all related articles

Mortality from benign prostatic hyperplasia (BPH) has significantly decreased in Western countries due to improved medical and surgical care. However, higher rates persist in Eastern Europe and South America, highlighting a need for better access to modern treatments.

Area of Science:

  • Urology
  • Public Health
  • Medical History

Background:

  • Benign prostatic hyperplasia (BPH) has historically been a significant cause of mortality.
  • Understanding international mortality trends is crucial for public health initiatives.

Purpose of the Study:

  • To systematically examine global mortality data for BPH between 1950 and 1990.
  • To identify and analyze changes in the international mortality patterns of BPH.

Main Methods:

  • Utilized mortality data from the World Health Organization database.
  • Focused on cases where BPH was the underlying cause of death.
  • Included data from various international countries, with records extending back to 1950 for many.

Main Results:

Related Experiment Videos

  • Observed substantial decreases in BPH mortality rates in developed Western nations from the early 1950s to the late 1980s.
  • Attributed these declines to advancements in BPH complication management, surgical techniques, and anesthesia.
  • Noted significant reductions in deaths in the UK, US, and France.

Conclusions:

  • The observed mortality reductions in Western countries represent a major, yet often unrecognized, success of modern medicine.
  • Significant disparities in mortality reduction exist, with Central/Eastern Europe and South America showing less improvement.
  • Educational initiatives and wider access to modern surgical and anesthetic equipment are recommended to reduce residual high mortality rates in underserved regions.